首頁 › 腎臟癌（腎細胞癌） › 密西根 › Ann Arbor
Ann Arbor, MI 的 腎臟癌（腎細胞癌） 臨床試驗
12 項針對 腎臟癌（腎細胞癌） 的研究正在 Ann Arbor（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 距離 7 英里
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距離 7 英里
- 還有 4 項
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 距離 7 英里
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距離 7 英里
- 還有 4 項
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
招募中2 期
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距離 7 英里
- 還有 4 項
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
招募中1 期
- University of Michigan, Ann Arbor
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
招募中3 期
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距離 7 英里
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 距離 15 英里
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 距離 18 英里
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
招募中1 期
- University of Michigan, Ann Arbor
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
招募中1/2 期
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
招募中3 期
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距離 7 英里
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 距離 15 英里
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 距離 18 英里
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
招募中1 期
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
招募中2 期
- University of Michigan, Ann Arbor
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
招募中1 期
- University of Michigan Hospitals, Ann Arbor
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
招募中3 期
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 距離 18 英里
其他城市的 腎臟癌（腎細胞癌） 試驗
- Houston, TX35 項研究
- New York City, NY27 項研究
- Dallas, TX23 項研究
- Nashville, TN23 項研究
- St. Louis, MO23 項研究
- Los Angeles, CA20 項研究
- Boston, MA16 項研究
- Baldwin Park, CA16 項研究
- Pittsburgh, PA15 項研究
- Philadelphia, PA15 項研究
- Queens, NY15 項研究
- Cleveland, OH14 項研究
Ann Arbor 的其他研究
- 乳癌27 項研究
- 前列腺癌27 項研究
- 非小細胞肺癌26 項研究
- 癌症（所有類型）25 項研究
- 肺癌23 項研究
- 大腸直腸癌23 項研究
- 心臟衰竭22 項研究
- 急性髓系白血病17 項研究
- 心血管疾病16 項研究
- 胰臟癌14 項研究
- 黑色素瘤12 項研究
- 中風12 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。